Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

We are looking into a health alert, as the FDA has ruled compounded versions of popular drugs used for weight loss will no ...

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

Mounting competition in the sector and rising obesity have led the pharmaceutical company to start selling the drug directly ...

Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...

Compare ADHD medications Vyvanse (lisdexamfetamine) vs. Concerta (methylphenidate). Understand their similarities and ...

Drinking artificially sweetened beverages may reduce metformin’s effectiveness in young patients with obesity and prediabetes ...

When her mother suggested she try a weight-loss drug ... If the group not taking the drug had benefited from the more intensive coaching, he believes the comparison would be fairer.

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity. This includes Wegovy (the weight-loss dose of Ozempic, or semaglutide ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

The number of drug-related fatalities in the UK linked to diabetes and weight loss medications has risen to 82, according to new data from the Medicines and Healthcare Products Regulatory Agency ...